ESMO Preceptorship on Ovarian Cancer 2022: Lisbon

Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties.

Learning objectives

• To learn about best clinical practice in the multidisciplinary management of early and late stage ovarian cancer
• To understand the importance of biology and pathology of common and rare ovarian tumours
• To understand the options for treatment of recurrent disease and how treatment-decisions are made
• To understand the novel therapeutic agents being developed to treat ovarian cancer and how knowledge of genomics and molecular pathways guides drug development
• To learn about the management of patients with symptoms of the disease and the side-effects of treatment